These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7102538)

  • 21. The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol.
    Simon H; Schuppan U
    Arzneimittelforschung; 1983; 33(2a):318-21. PubMed ID: 6340700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
    Kostis JB; Lacy CR; Krieger SD; Cosgrove NM
    Am Heart J; 1984 Oct; 108(4 Pt 2):1131-6. PubMed ID: 6148873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early work load tests for evaluation of long-term prognosis of acute myocardial infarction.
    Granath A; Södermark T; Winge T; Volpe U; Zetterquist S
    Br Heart J; 1977 Jul; 39(7):758-63. PubMed ID: 884025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pindolol for ventricular arrhythmia.
    Podrid PJ; Lown B
    Am Heart J; 1982 Aug; 104(2 Pt 2):491-6. PubMed ID: 7102535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ST-segment/heart rate loop analysis on treadmill exercise testing can provide diagnostic and prognostic information in patients with stable effort angina.
    Kamata J; Nakai K; Kawazoe K; Hiramori K
    Coron Artery Dis; 1995 Jul; 6(7):547-54. PubMed ID: 7582193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptom-limited vs heart-rate-limited exercise testing soon after myocardial infarction.
    DeBusk RF; Haskell W
    Circulation; 1980 Apr; 61(4):738-43. PubMed ID: 7357715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [LB-46 in the treatment of angina pectoris, arrhythmia and functional cardiac disorders].
    Latorre A; Lenti M; Calabrese P
    Minerva Cardioangiol; 1976 Sep; 24(9):619-24. PubMed ID: 1012502
    [No Abstract]   [Full Text] [Related]  

  • 28. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ergometric evaluation of the cardioprotective effect of pindolol in coronary disease. Comparison of 2 galenic forms].
    Mérier GR; Perrenoud JJ
    Schweiz Med Wochenschr; 1988 Jul; 118(26):1016-20. PubMed ID: 3413461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris.
    Dwyer EM; Pepe AJ; Pinkernell BH
    Am Heart J; 1982 May; 103(5):830-3. PubMed ID: 6803556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and experimental study of antiarrhythmic and antianginal effects of quaternidine.
    Kostin YV; Sernov LN; Moiseeva IY; Kulikova NN; Shmyreva MV; Klimovich YG
    Bull Exp Biol Med; 2000 Nov; 130(11):1113-5. PubMed ID: 11182831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of reducing circulating free fatty acids on ventricular arrhythmias during myocardial infarction and on ST-segment depression during exercise-induced ischemia.
    Oliver MF; Rowe MJ; Luxton MR; Miller NE; Neilson JM
    Circulation; 1976 Mar; 53(3 Suppl):I210-3. PubMed ID: 767017
    [No Abstract]   [Full Text] [Related]  

  • 33. [A new beta-blocker, LB 46--Visken].
    Oulhaci M; Merad B; Toumi N; Ait-Amar M; Boudjellab A; Issad M; Piva G
    Tunis Med; 1973 Nov; 51(6):369-73. PubMed ID: 4137366
    [No Abstract]   [Full Text] [Related]  

  • 34. Bopindolol in chronic stable angina pectoris: duration and extent of antianginal action.
    Carboni GP; Scardovi AB; D'Ermo M; Prati PL
    Br J Clin Pharmacol; 1991 Dec; 32(6):755-7. PubMed ID: 1685090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of arrhythmias accompanying ST-segment depression on ambulatory monitoring in stable angina pectoris.
    Carboni GP; Lahiri A; Cashman PM; Raftery EB
    Am J Cardiol; 1987 Dec; 60(16):1246-53. PubMed ID: 3687776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The efficiency of coronary therapy with Visken (pindolol). A combined clinical and experimental analysis (author's transl)].
    Delius L; Lübke KO
    Med Klin; 1974 Jun; 69(25):1117-23. PubMed ID: 4602393
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propranolol and LB 46 (prinodolol) in angina pectoris. A comparative long-term ergometric study.
    Arstila M; Kallio V; Wendelin H
    Ann Clin Res; 1973 Apr; 5(2):91-100. PubMed ID: 4201295
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo].
    Hopf R; Drews H; Kaltenbach M
    Z Kardiol; 1984 Sep; 73(9):578-85. PubMed ID: 6391005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.